Page 77 - GALENIKA MEDICAL JOURNAL

Literatura 11. Bangalore S, Fayyad R, Laskey R, Demicco DA, Deedwania P, Kostis JB,
et al; Treating to New Targets Steering Committee and Investigators.
Prevalence, predictors, and outcomes in treatment-resistant
1. Al Ghorani H, Götzinger F, Böhm M, Mahfoud F. Arterial hypertension hypertension in patients with coronary disease. Am J Med. 2014
- Clinical trials update 2021. Nutr Metab Cardiovasc Dis. 2022 Jan;127(1):71-81.e1.
Jan;32(1):21-31. 12. Irvin MR, Booth JN 3rd, Shimbo D, Lackland DT, Oparil S, Howard G,
2. Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, et et al. Apparent treatment-resistant hypertension and risk for stroke,
al. Achieved blood pressure and cardiovascular outcomes in high-risk coronary heart disease, and all-cause mortality. J Am Soc Hypertens.
patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017 2014 Jun;8(6):405-13.
Jun 3;389(10085):2226-37. 13. Egan BM, Kai B, Wagner CS, Henderson JH, Chandler AH, Sinopoli A.
3. Kjeldsen SE, Lund-Johansen P, Nilsson PM, Mancia G. Unattended Blood Blood Pressure Control Provides Less Cardiovascular Protection in
Pressure Measurements in the Systolic Blood Pressure Intervention Adults With Than Without Apparent Treatment-Resistant Hypertension.
Trial: Implications for Entry and Achieved Blood Pressure Values J Clin Hypertens (Greenwich). 2016 Aug;18(8):817-24.
Compared With Other Trials. Hypertension. 2016 May;67(5):808-12. 14. Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, et al.
4. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure First International Consensus on the diagnosis and management of
lowering on outcome incidence in hypertension: 7. Effects of more vs. fibromuscular dysplasia. Vasc Med. 2019 Apr;24(2):164-89.
less intensive blood pressure lowering and different achieved blood 15. Rossi GP, Pavan E, Chiesura-Corona M, Bader M, Paganini G, Cesari
pressure levels - updated overview and meta-analyses of randomized M, et al. Renovascular hypertension with low-to-normal plasma renin:
trials. J Hypertens. 2016 Apr;34(4):613-22. clinical and angiographic features. Clin Sci (Lond). 1997 Nov;93(5):435-
5. Peacock E, Krousel-Wood M. Adherence to Antihypertensive Therapy. 43.
Med Clin North Am. 2017 Jan;101(1):229-45. 16. Rossi GP, Seccia TM, Pessina AC. Secondary hypertension: the ways of
6. Pisano A, Iannone LF, Leo A, Russo E, Coppolino G, Bolignano D. Renal management. Curr Vasc Pharmacol. 2010 Nov;8(6):753-68.
denervation for resistant hypertension. Cochrane Database Syst Rev. 17. Schmieder RE, Mahfoud F, Mancia G, Azizi M, Böhm M, Dimitriadis K,
2021 Nov 22;11(11):CD011499. et al; members of the ESH Working Group on Device-Based Treatment
7. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. of Hypertension. European Society of Hypertension position paper on
Resistant hypertension: diagnosis, evaluation, and treatment. A renal denervation 2021. J Hypertens. 2021 Sep 1;39(9):1733-41.
scientific statement from the American Heart Association Professional 18. Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh
Education Committee of the Council for High Blood Pressure Research. K, Townsend RR, et al; SYMPLICITY HTN-3 Steering Committee
Hypertension. 2008 Jun;51(6):1403-19. Investigators. Long-term outcomes after catheter-based renal
8. Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison- artery denervation for resistant hypertension: final follow-up
Himmelfarb CR, et al; American Heart Association Professional/Public of the randomised SYMPLICITY HTN-3 Trial. Lancet. 2022 Oct
Education and Publications Committee of the Council on Hypertension; 22;400(10361):1405-16.
Council on Cardiovascular and Stroke Nursing; Council on Clinical
Cardiology; Council on Genomic and Precision Medicine; Council on
Peripheral Vascular Disease; Council on Quality of Care and Outcomes
Research; and Stroke Council. Resistant Hypertension: Detection, Konflikt interesa: Nema
Evaluation, and Management: A Scientific Statement From the
American Heart Association. Hypertension. 2018 Nov;72(5):e53-e90. Primljeno: 26. 02. 2023.
9. Smith SM, Gong Y, Handberg E, Messerli FH, Bakris GL, Ahmed A, et Prihvaćeno: 04. 03. 2023.
al. Predictors and outcomes of resistant hypertension among patients Onlajn: 01. 06. 2023.
with coronary artery disease and hypertension. J Hypertens. 2014
Mar;32(3):635-43.
10. Smith SM, Huo T, Delia Johnson B, Bittner V, Kelsey SF, Vido Thompson
D, et al. Cardiovascular and mortality risk of apparent resistant
hypertension in women with suspected myocardial ischemia: a report
from the NHLBI-sponsored WISE Study. J Am Heart Assoc. 2014 Feb
28;3(1):e000660.

REVIJALNI RADOVI Galenika Medical Journal, 2023; 2(6):71-75. 75